Newsfeeds - Spark Newswire

1 minute read

Roche’s Another Alzheimer’s Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months

November 14, 8:23 AM

MorphoSys AG’s (NASDAQ:MOR) partner Roche Holdings AG (OTC:RHHBY) announced results from the GRADUATE I and II studies evaluating gantenerumab in mild cognitive impairment…

MOR

1 minute read

Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests

By Vandana Singh

October 12, 6:53 AM

Roche Holdings AG (OTC:RHHBY) has announced the launch of its next-generation portfolio of COVID-19 rapid antigen tests (2.0) for self-testing and…

RHHBF

1 minute read

FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests

By Vandana Singh

September 27, 2:14 PM

The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…

1 minute read

Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders

By Vandana Singh

September 19, 10:40 AM

The European Commission approved Roche Holding AG’s (OTC:RHHBY) Vabysmo (faricimab) for neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment…

REGN

1 minute read

No More Free COVID-19 At-Home Tests, Federal Government Says

By Vandana Singh

August 29, 8:20 AM

CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au

1 minute read

Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate

By Vandana Singh

August 25, 2:45 PM

Citi has increased peak risk-adjusted Eli Lilly And Co's (NYSE: LLY) tirzepatide forecasts (diabetes/ obesity/NASH) to more than $25 billion (previously $15 billion, consensus of around $16 billion).

ESALF

1 minute read

China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche’s Genentech

By Vandana Singh

August 18, 12:07 PM

After penning a deal with Orion in May for a non-opioid pain drug, Jemincare is back at the…

RHHBF

1 minute read

Roche’s Polivy Combo Regime Under FDA Review For Type Of Blood Cancer

By Vandana Singh

August 16, 2:59 PM

Roche Holdings AG (OTC:RHHBY) announced that the FDA accepted its supplemental marketing application for Polivy. Polivy is being developed by Roche…

RHHBF

1 minute read

FDA Approves Expanded Use Of Roche’s Influenza Treatment

By Vandana Singh

August 12, 11:21 AM

The FDA has approved the expanded use of Roche Holding AG’s (OTC:RHHBY) Xofluza (baloxavir marboxil). The medicine has been approved to treat…

RHHBF

1 minute read

Regeneron’s Price Target Cut On Dim Prospects For Its Flagship Eye Product

By Vandana Singh

July 25, 12:25 PM

SVB has cut the price target from $738 to $630 and downgraded from Outperform to Market Perform to reflect Regeneron Pharmaceutical Inc’s (NASDAQ:REGN)…

REGN